|
|
||||||||
CONCISE REVIEW |
a University of Queensland, Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
b Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Key Words. Dendritic cells • Differentiation • Rheumatoid arthritis • Stem cell • Precursor • Antigen • Endocytosis • Lineage
Dr. R. Thomas, University of Queensland, Department of Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia.
Dendritic cells (DC) are bone marrow-derived cells that are specialized to take up, process and present antigen, and have the capacity to stimulate resting T cells in the primary immune response. DC are a unique population that is likely to derive from a myeloid precursor cell. DC differentiation from bone marrow precursors is enhanced by the cytokines GM-CSF and tumor necrosis factor-
. In contrast, it has been proposed that thymic DC and T cells arise from a common stem cell, and that these DC play a specific role in the negative selection of thymic T cells. A number of post-bone marrow differentiation stages can be defined phenotypically and functionally. Undifferentiated DC have very active endocytic pathways, including receptor-mediated endocytosis involving a mannose/ß glucan receptor, and macropinocytosis of soluble antigen. In contrast, later stages of maturation are associated with a decreased ability to take up and process antigen, and increasing expression of major histocompatibility complex, adhesion and costimulatory molecules. Finally, activation of DC for full antigen-presenting cell function can be identified by the expression of CD28 ligands. The inflammatory site in rheumatoid arthritis is a human model of DC differentiation in response to a chronic antigenic stimulus. The features of this DC model are discussed.
This article has been cited by other articles:
![]() |
T. Nikolic, M. F. T. R. d. Bruijn, M. B. Lutz, and P. J. M. Leenen Developmental stages of myeloid dendritic cells in mouse bone marrow Int. Immunol., April 1, 2003; 15(4): 515 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Dixon, K. B. Knopf, and W. D. Figg The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents Pharmacol. Rev., March 1, 2001; 53(1): 73 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brasel, T. De Smedt, J. L. Smith, and C. R. Maliszewski Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures Blood, November 1, 2000; 96(9): 3029 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Small, D. M. Reese, B. Um, S. Whisenant, S. C. Dixon, and W. D. Figg Therapy of Advanced Prostate Cancer with Granulocyte Macrophage Colony-stimulating Factor Clin. Cancer Res., July 1, 1999; 5(7): 1738 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Tjurmin, N. M. Ananyeva, E. P. Smith, Y. Gao, M. K. Hong, M. B. Leon, and C. C. Haudenschild Studies on the Histogenesis of Myxomatous Tissue of Human Coronary Lesions Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 83 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Santiago-Schwarz, M. McCarthy, J. Tucci, and S. E. Carsons Neutralization of Tumor Necrosis Factor Activity Shortly After the Onset of Dendritic Cell Hematopoiesis Reveals a Novel Mechanism for the Selective Expansion of the CD14-Dependent Dendritic Cell Pathway Blood, August 1, 1998; 92(3): 745 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Page, E. M. Roberts, J. J. Peschon, and S. M. Hedrick TNF Receptor-Deficient Mice Reveal Striking Differences Between Several Models of Thymocyte Negative Selection J. Immunol., January 1, 1998; 160(1): 120 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Grouard, M.-C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y.-J. Liu The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand J. Exp. Med., March 17, 1997; 185(6): 1101 - 1112. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
